Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Trucco

Showing results (21-30 of 175) with videos related to

Pageof 18
Sort By:
Current Pharmaceutical Design|August 26, 2011
Immunotherapy-based strategies for the treatment of autoimmune diabetes: searching for the cureBrett E Phillips, Massimo Trucco
Pediatric Diabetes|March 8, 2007
To be DR8 or not to be DQ8, that is the questionWilliam A Rudert, Massimo Trucco
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Genes and engineered cells as drugs for type I and type II diabetes mellitus therapy and preventionNick Giannoukakis, Massimo Pietropaolo, Massimo Trucco
Contributions to Nephrology|April 9, 2008
Renal diseases as targets of gene therapyBrett Phillips, Nick Giannoukakis, Massimo Trucco
Advanced Drug Delivery Reviews|December 7, 2007
Induction of immune tolerance to facilitate beta cell regeneration in type 1 diabetesLorenzo Pasquali, Nick Giannoukakis, Massimo Trucco
Nature Immunology|March 29, 2002
Cellular environment and freedom of gene expressionMassimo Pietropaolo, Nick Giannoukakis, Massimo Trucco
Clinical Immunology (Orlando, Fla.)|March 31, 2015
A brief glimpse over the horizon for type 1 diabetes nanotherapeuticsYesica Garciafigueroa, Massimo Trucco, Nick Giannoukakis
Expert Review of Clinical Immunology|May 19, 2010
Dendritic cell-based therapy in Type 1 diabetes mellitusBrett Phillips, Nick Giannoukakis, Massimo Trucco
Pediatric Diabetes|June 11, 2008
Toward a cure for type 1 diabetes mellitus: diabetes-suppressive dendritic cells and beyondNick Giannoukakis, Brett Phillips, Massimo Trucco
Pediatric Clinics of North America|November 23, 2005
A look to the future: prediction, prevention, and cure including islet transplantation and stem cell therapyAnna Casu, Massimo Trucco, Massimo Pietropaolo
Pageof 18

Showing results (21-30 of 175) with videos related to

Sort By:
Pageof 18
Current Pharmaceutical Design|August 26, 2011
Immunotherapy-based strategies for the treatment of autoimmune diabetes: searching for the cureBrett E Phillips, Massimo Trucco
Pediatric Diabetes|March 8, 2007
To be DR8 or not to be DQ8, that is the questionWilliam A Rudert, Massimo Trucco
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Genes and engineered cells as drugs for type I and type II diabetes mellitus therapy and preventionNick Giannoukakis, Massimo Pietropaolo, Massimo Trucco
Contributions to Nephrology|April 9, 2008
Renal diseases as targets of gene therapyBrett Phillips, Nick Giannoukakis, Massimo Trucco
Advanced Drug Delivery Reviews|December 7, 2007
Induction of immune tolerance to facilitate beta cell regeneration in type 1 diabetesLorenzo Pasquali, Nick Giannoukakis, Massimo Trucco
Nature Immunology|March 29, 2002
Cellular environment and freedom of gene expressionMassimo Pietropaolo, Nick Giannoukakis, Massimo Trucco
Clinical Immunology (Orlando, Fla.)|March 31, 2015
A brief glimpse over the horizon for type 1 diabetes nanotherapeuticsYesica Garciafigueroa, Massimo Trucco, Nick Giannoukakis
Expert Review of Clinical Immunology|May 19, 2010
Dendritic cell-based therapy in Type 1 diabetes mellitusBrett Phillips, Nick Giannoukakis, Massimo Trucco
Pediatric Diabetes|June 11, 2008
Toward a cure for type 1 diabetes mellitus: diabetes-suppressive dendritic cells and beyondNick Giannoukakis, Brett Phillips, Massimo Trucco
Pediatric Clinics of North America|November 23, 2005
A look to the future: prediction, prevention, and cure including islet transplantation and stem cell therapyAnna Casu, Massimo Trucco, Massimo Pietropaolo
Pageof 18